Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Expert Opinion on Drug Discovery|November 24, 2021
Assay development in leishmaniasis drug discovery: a comprehensive reviewBilal Zulfiqar, Vicky M AveryJournal of Cancer & Allied Specialties|May 17, 2023
Indoleamine 2,3-Dioxygenase: A Novel Immunotherapeutic Target for OsteosarcomaAsim Farooq, Bilal Zulfiqar, Kashif AsgharDrug Discovery Today|June 26, 2017
Leishmaniasis drug discovery: recent progress and challenges in assay developmentBilal Zulfiqar, Todd B Shelper, Vicky M AveryFrontiers in Pharmacology|December 15, 2022
Immunotherapy and targeted therapy for lung cancer: Current status and future perspectivesBilal Zulfiqar, Asim Farooq, Shahzina Kanwal, et al.World Journal of Clinical Oncology|June 30, 2021
Review of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenaseKashif Asghar, Asim Farooq, Bilal Zulfiqar, et al.World Journal of Gastroenterology|April 22, 2017
Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinomaKashif Asghar, Asim Farooq, Bilal Zulfiqar, et al.Experimental and Therapeutic Medicine|February 11, 2015
Indoleamine 2,3-dioxygenase expression and activity in patients with hepatitis C virus-induced liver cirrhosisKashif Asghar, M Taimour Ashiq, Bilal Zulfiqar, et al.SLAS Discovery : Advancing Life Sciences R & D|February 19, 2026
An MRC-5 cell based high-throughput, high-content imaging assay to identify hits against Trypanosoma cruzi intracellular parasitesBilal Zulfiqar, Melissa L Sykes, Fanny B Escudié, et al.Biology|March 26, 2025
Connecting Bone Remodeling and Regeneration: Unraveling Hormones and Signaling PathwaysAfshan Mehreen, Muhammad Faisal, Bilal Zulfiqar, et al.Oncotargets and Therapy|February 9, 2017
Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitorsBilal Zulfiqar, Amnah Mahroo, Kaenat Nasir, et al.Pageof 3